These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Systemic scleroderma in children]. Plantin P; Gavanou J; Le Fur JM; Guillet G Arch Fr Pediatr; 1988 Dec; 45(10):805-8. PubMed ID: 3266459 [TBL] [Abstract][Full Text] [Related]
23. Care of patients with scleroderma in the intensive care setting. Farber HW; Simms RW; Lafyatis R J Intensive Care Med; 2010 Sep; 25(5):247-58. PubMed ID: 20542965 [TBL] [Abstract][Full Text] [Related]
24. [M scleroderma (with systemic progressive sclerosis) associated with clinical and biological signs of dermatomyositis and lupus erythematosus]. Grupper C; Durepaire RM; Eisenmann D; Briche R Bull Soc Fr Dermatol Syphiligr; 1972; 79(3):219-20. PubMed ID: 4642837 [No Abstract] [Full Text] [Related]
25. The spectrum of scleroderma (II). LeRoy EC; Lomeo R Hosp Pract (Off Ed); 1989 Nov; 24(11):65-8, 69-72, 75-6 passim. PubMed ID: 2509504 [No Abstract] [Full Text] [Related]
26. Vascular disease in systemic sclerosis. Poredos P Vasa; 2011 Jan; 40(1):3-4. PubMed ID: 21375075 [No Abstract] [Full Text] [Related]
28. [A case of systemic sclerosis in childhood complicated by severe digital ulcers]. Falcini F; Volpi M; Pierattelli M; Taccetti G; Pratesi G; Matucci Cerinich M Pediatr Med Chir; 1984; 6(5):703-7. PubMed ID: 6535137 [TBL] [Abstract][Full Text] [Related]
29. Possible adverse effect of phenoxybenzamine therapy in a patient with progressive systemic sclerosis. Parker LP; Hahn BH; Osterland CK Arthritis Rheum; 1972; 15(5):535-9. PubMed ID: 4634806 [No Abstract] [Full Text] [Related]
40. Raynaud's phenomenon affecting the tongue of a patient with scleroderma. Bridges MJ; Kelly CA Ann Rheum Dis; 2002 May; 61(5):472. PubMed ID: 11959778 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]